LinaThera reposted this
⚡ Exciting developments at Nuclidium as we prepare for LSX - partnering for Life Science eXecutives! ⚡ Investments by industry giants like Lilly and BMS highlight the potential and competitive nature of the radiopharmaceutical sector. Here’s why you should meet with Leila Jaafar and Andreas Schuh on the 29th and 30th of April in London: ✅ Innovative Theranostics: Our Cu-61 and Cu-67 pairs offer precise diagnosis and targeted treatment, improving efficacy and minimizing side effects for major cancers such as breast, prostate, lung, and pancreatic. ✅ Advanced Diagnostics: Cu-61’s longer half-life and superior properties simplify manufacturing and extend usability, enhancing diagnostic applications. ✅ Effective Therapeutics: Cu-67 aligns perfectly with our targeting molecules, allowing for higher tumor dosage with reduced toxicity and shorter hospital stays. ✅ Sustainable Production: In collaboration with LinaThera, our proprietary, scalable production facilities are independent of nuclear reactors, beginning in Germany with plans for global expansion. With commitments secured and a strategic investor on board, we're gearing to close Series A2 in Q3. Join us at LSX - partnering for Life Science eXecutives to discover how our cutting-edge solutions are poised to revolutionize cancer treatment. #LSX #Radiopharmaceuticals #InvestInInnovation #LinaThera #Nuclidium
